1231892-49-1

Basic information

• Product Name: 6-tert-butyl-2-(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isoindolin-1-one
• Synonyms: 6-tert-butyl-2-(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isoindolin-1-one
• CAS NO: 1231892-49-1
• Molecular Weight: 405.345
• Mol File: 1231892-49-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-tert-butyl-2-(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isoindolin-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-tert-butyl-2-(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isoindolin-1-one(1231892-49-1)
• EPA Substance Registry System: 6-tert-butyl-2-(2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)isoindolin-1-one(1231892-49-1)

Safety Data

• Hazardous Substances Data: 1231892-49-1(Hazardous Substances Data)

Upstream product

• 1361386-73-3 6-tert-butylisoindolin-1-one 
• 1361386-72-2 5-tert-butyl-2-((3,3-dimethylureido)methyl)benzoic acid 
• 7364-19-4 4-ethyl-tert-butylbenzene 
• 1231890-99-5 2-(3-bromo-2-methylphenyl)-6-tert-butylisoindolin-1-one 
• 73183-34-3 bis(pinacol)diborane 

Relevant articles and documents

PYRIDAZINONES, METHOD OF MAKING, AND METHOD OF USE THEREOF

Pyridazinone compounds of Formula (I) including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula (I) for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.